Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Summary
The study is being conducted to evaluate the efficacy and safety of HRS-7249 for patients with hyperlipidemia, and to explore the reasonable dosage of HRS-7249 for patients with hyperlipidemia.
Official title: A Multicenter, Randomized, Placebo-controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of HRS-7249 in Patients With Hyperlipidemia
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2025-08-12
Completion Date
2027-01
Last Updated
2025-09-10
Healthy Volunteers
No
Conditions
Interventions
HRS-7249 Injection
HRS-7249 injection.
Sodium Chloride Injection
Sodium chloride injection.
Locations (1)
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China